A pan-cancer analysis reveals the multifaceted role of PABPC1L in immune regulation and therapy response
An integrated pan-cancer analysis of PABPC1L expression and function in 33 human malignant tumors identified PABPC1L as exhibiting oncogenic properties and is proposed to function as a key regulator of tumorigenesis and immunotherapy resistance.